BellRing Brands, Inc.
Built from real-time financials, refreshed daily. For a full Analyst Grade with bull/bear case, price targets, and qualitative risk analysis, generate a BRBR research report →
Range $11 – $15
Price Chart
About the company
BellRing Brands Inc. , along with its various subsidiaries, is a provider of diverse nutritional products, serving both the United States and international markets. The company's main offerings are protein-fortified ready-to-drink shakes and powdered protein supplements, which are primarily marketed under its well-known Premier Protein and Dymatize labels.
- CEO
- Mike Axelrod
- IPO
- 2019
- Employees
- 530
- HQ
- Saint Louis, MO, US
Get TickerSpark's AI analysis on BRBR
Create an account to generate AI analysis on any ticker — technical setup, analyst consensus, earnings watch, insider pulse, financial health, and peer context. Ready in about a minute.
Get Pro Access →Already have an account? Log in
Similar companies
Peers in the same neighborhood.
- Market Cap
- $1.22B
- P/E
- 7.36
- Fwd P/E
- 10.08
- PEG
- 0.01
- P/S
- 0.52
- P/B
- -2.62
- EV/EBITDA
- 7.07
- Div Yield
- 0.00%
- Gross Margin
- 27.30%
- Op Margin
- 12.33%
- Net Margin
- 7.28%
- ROE
- -35.53%
- ROIC
- 30.24%
Latest fiscal year · YoY change
- Revenue
- $2.32B+16.1%
- Gross Profit
- $770.40M+8.9%
- Op Income
- $357.40M
- Net Income
- $216.20M-12.3%
- EPS
- $1.70-10.1%
- OCF Growth
- +30.6%
- FCF Growth
- +29.4%
- 52W High
- $43.02
- 52W Low
- $7.82
- 50D MA
- $11.68
- 200D MA
- $18.30
- Beta
- 0.52
- RSI (14)
- 38
- Avg Volume
- 5.19M
Earnings call summaries
Pick a quarter — each call distilled into takeaways, results, and a bull vs bear read.
BellRing posted solid top-line growth in Q3, but heavy protein, freight and inventory-related costs pressured margins, prompting a revised FY26 outlook and a series of pricing and productivity actions for FY27.· August 4, 2026
- Q3 net sales increased 4%, led by better-than-expected performance from Premier Protein and Dymatize.
- Adjusted gross margin fell to 27.7% from 35.1% a year ago, with management citing protein inflation, freight costs and a bottled-shake inventory charge.
- Full-year FY26 net sales guidance was raised to $2.335 billion-$2.375 billion, but adjusted EBITDA guidance was cut to $275 million-$295 million, or about 12% margin.
- Management announced double-digit price increases on Premier shakes and additional pricing on powders effective in Q1 FY27.
- The company expects improved margins in FY27, helped by pricing, productivity actions, organizational realignment savings and supply-chain improvements.
Q3 net sales increased 4%. Premier Protein brand and RTD shake net sales increased 1%, with shake volume up 3%, price/mix down 2%, and dollar consumption up 6%. Dymatize net sales increased 27%, with volumes up 6% and price/mix up 21%. Adjusted gross profit was $158 million and adjusted gross margin was 27.7% versus 35.1% a year ago. SG&A was $94 million, or 16.4% of sales, including a $7 million advertising increase and a $5 million organizational realignment charge. Operating cash flow was $79 million and net leverage ended at 3.2x. For FY26, management now expects net sales of $2.335 billion-$2.375 billion, adjusted EBITDA of $275 million-$295 million, and a margin of approximately 12%. The outlook includes $28 million of unfavorable inventory-related impacts, with $21 million already recorded in Q2 and Q3, and tariffs are expected to be an 80 basis point margin headwind for the year. For Q4, net sales are expected to be flat at the midpoint and adjusted EBITDA margin is expected to be approximately 10%.
Mike Axelrod struck an upbeat but candid tone, saying he sees BellRing’s category and brand strength as durable even though current performance has been hurt by transitory factors. He emphasized that Premier Protein remains the category leader with strong consumer demand and a long runway for growth, but said execution has not been consistent enough and that he is focused on listening, improving accountability and building a more disciplined operating model. He framed the near-term challenges as manageable and said he expects to share more on strategic priorities and 2027 guidance on the next call.
Paul Rode focused on the drivers behind the quarter and the recovery plan. He said Q3 beat on sales and consumption, but margins missed due to inventory-related headwinds, higher freight costs and protein inflation; adjusted gross margin was 27.7% versus 35.1% last year. He detailed $28 million of unfavorable inventory-related impacts in FY26, $10 million to $12 million of annualized savings from the June organizational realignment, and a year-end net leverage expectation of about 4x due to a sizable legal settlement in Q4. He also said freight rates stepped up sharply in Q3 and are expected to remain elevated into Q4 and carry a bit into next year, while whey and milk protein costs are still expected to stay elevated.
Analysts pressed on whether FY26 is a trough, whether BellRing needs more ongoing marketing support, and how pricing can offset cost inflation without hurting volume. Management said FY26 is not the new normal, expects FY27 margins to improve, and pointed to a double-digit Premier shake price increase plus pricing on Dymatize powders, along with productivity and reorganization savings. Questions also focused on the cause of excess bottle inventory, with Paul Rode explaining that tetra packs cannibalized bottles more than expected and that demand and supply planning did not react quickly enough, leading to a $10 million reserve and Q4 trade spend to clear inventory. On innovation and distribution, management highlighted the launch of Premier Protein Ultimate and Sparkling Soda, plus targeted regional DSD expansion into convenience and continued gains in FDM and e-commerce.
The bull case from this call is that BellRing still has strong category fundamentals: consumer demand for RTD protein remains healthy, household penetration is still only almost 23%, and Premier continues to have the highest repeat rate in the category. Management is taking concrete actions on pricing, productivity, innovation and channel expansion, and believes these steps should support better margins starting in FY27.
The bear case is that FY26 has been hit by several overlapping headwinds: protein inflation, sharply higher freight, tariffs, and inventory problems in the bottles business. Management also expects Q4 to remain pressured, with about 10% adjusted EBITDA margin and continued promotional intensity, while the new price increases carry elasticity risk greater than 1 and could weigh on volumes or inventory sell-through.
AI summary of the company's earnings call · Paraphrased · Not investment advice
- Free Float
- 98.2%
- Shares Outstanding
- 116.28M
- Float Shares
- 114.21M
of shares held by institutions
401 13F filers
Buy/sell ratio 0.00. Sells can include pre-scheduled 10b5-1 plan sales, not just discretionary selling.
Congressional trading
Senate and House stock disclosures for BRBR, newest first.
Source: public STOCK Act disclosures. Filed weeks after the trade — a lagging signal, not a real-time one.
Top institutional holders
Largest 13F positions, with quarter-over-quarter change.
| Holder | Shares | Δ Quarter |
|---|---|---|
| Vanguard Group Inc | 11.87M | ▼ 157.88K |
| Blackrock, Inc. | 10.94M | ▼ 333.07K |
| Aqr Capital Management LLC | 6.07M | ▼ 2.47M |
| Ameriprise Financial Inc | 5.84M | ▲ 5.61M |
| Yacktman Asset Management LP | 5.26M | ▲ 3.77M |
| Vanguard Capital Management LLC | 5.25M | ▲ 35.95K |
| Goldman Sachs Group Inc | 5.19M | ▲ 3.63M |
| Two Sigma Investments, LP | 4.97M | ▲ 1.70M |
| Millennium Management LLC | 4.54M | ▲ 3.51M |
| Citadel Advisors LLC | 4.40M | ▲ 1.35M |
| Morgan Stanley | 3.53M | ▲ 1.12M |
| D. E. Shaw & Co., Inc. | 3.38M | ▲ 1.59M |
Held by 308 ETFs
Biggest fund positions in BRBR by dollar value.
Recent insider transactions
Who's buying, who's selling, and how much.
| Date | Insider | Type | Shares |
|---|---|---|---|
| Jul 29, 26 | Axelrod Michael Carey | other | 142,964 |
| Jul 29, 26 | Axelrod Michael Carey | other | 0 |
| Jul 1, 26 | Finkelstein David Isaiah | other | 2,447.131 |
| Jul 1, 26 | STEIN ELLIOT JR | other | 489.427 |
| Jul 1, 26 | VITALE ROBERT V | other | 4,507.873 |
| Jul 1, 26 | JOHNSON JENNIFER KUPERMAN | other | 2,382.733 |
| Jul 1, 26 | CONWAY SHAWN | other | 2,575.926 |
| Jul 1, 26 | Nwamu Chonda J | other | 2,447.131 |
| Jul 1, 26 | ERICKSON THOMAS P | other | 3,670.695 |
| May 13, 26 | Finkelstein David Isaiah | buy | 4,000 |
A “Sell” may be a pre-scheduled 10b5-1 plan sale rather than a discretionary decision — read insider selling with that in mind.
Our BRBR coverage
Recent articles, reports, and earnings notes.
No research on BRBR yet
For a full analyst-grade research report — grades, price targets, financials, chart analysis — generate one on demand.
Generate BRBR report →Kuehn Law Encourages Investors of BellRing Brands, Inc. to Contact Law Firm
prnewswire.com · Aug 19
BellRing Investor News: If You Own Stock in BellRing Brands, Inc., You Are Encouraged to Contact The Rosen Law Firm About Your Rights
newsfilecorp.com · Aug 19
Did BellRing Brands, Inc. Insiders Breach their Fiduciary Duties to Shareholders?
gurufocus.com · Aug 18
Did BellRing Brands, Inc. Insiders Breach their Fiduciary Duties to Shareholders?
prnewswire.com · Aug 18
BellRing Investor News: Rosen Law Firm Announces Investigation of Breaches of Fiduciary Duties by the Directors and Officers of BellRing Brands, Inc. – BRBR
globenewswire.com · Aug 18
Kuehn Law Encourages Investors of BellRing Brands, Inc. to Contact Law Firm
newsfilecorp.com · Aug 18
BellRing Investor News: Rosen Law Firm Announces Investigation of Breaches of Fiduciary Duties by the Directors and Officers of BellRing Brands, Inc. - BRBR
prnewswire.com · Aug 18
BellRing Investor News: If You Own Stock in BellRing Brands, Inc., You Are Encouraged to Contact The Rosen Law Firm About Your Rights
newsfilecorp.com · Aug 13
Headlines from third-party outlets — TickerSpark isn't affiliated with these sources.